TheraNews
Subscribe

Archive summary

Ozempic and Wegovy: Weight Rebound Risks After Stopping Treatment

GLP-1 drugs like Ozempic and Wegovy effectively aid weight loss by mimicking appetite-regulating hormones, but discontinuation often triggers intense hunger, rapid weight regain, and metabolic setbacks, as shown in studies. This rebound effect highlights the need for long-term commitment and structu

Summary of reporting by webpronews 1 min read Markdown

Original report

Ozempic and Wegovy: Weight Rebound Risks After Stopping Treatment
webpronews

About this article

  • Educational, not advice. Nothing here is medical, legal, billing or financial advice. Clinical decisions belong with a licensed clinician; coverage and legal questions belong with the payer, the statute or counsel. Prices and rates change; confirm them with the provider and the plan.
  • Corrections. If something on this page is wrong, send a correction with the source.

Topics: mental-health

Newsletter

The weekly digest

Weekly digest of US behavioral health policy and regulation, source-linked and practitioner-edited. Free; unsubscribe in one click.